Investigating the mechanisms of CD20 downregulation triggered by tyrosine kinase inhibitors in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia

2023/49/N/NZ5/04272

Keywords

Descriptors

  • NZ5_07: Leczenie chorób człowieka
  • NZ6_01: Odporność swoista i nieswoista

Panel

NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Voivodeship: mazowieckie

Other projects carried out by the institution »

Principal investigator (from the host institution)

Krzysztof Domka

Number of co-investigators in the project: 3

Call

PRELUDIUM 22 – announced on 2023-03-16

Amount awarded
204 906 PLN
Project start date
2024-06-17
Project end date
2027-06-16
Project duration
36 months (the same as in the proposal)
Project status
Pending project

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

« New search

Graphic design and implementation: Jakub Piotrowski